Patent US6048873A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6048873A Expired / Lapsed US ⏱️ 0.0 years remaining

Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity

Assignee: Allergan Inc
•
Filing: 1998-10-01
•
Granted: 2000-04-11
•
Expires: 2018-10-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of Formula 1 ##STR1## where Y is a bivalent radical having Formula 2 or Formula 3 where o is an integer from 1 to 4 ##STR2## where the remaining symbols have the meaning described in the specification are selective agonists of RXR retinoid receptors.

Inventors

  • 👤 Jayasree Vasudevan
  • 👤 Vidyasagar Vuligonda
  • 👤 Richard L. Beard
  • 👤 Roshantha A. Chandraratna

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 06:43
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/12; A; A61; A61P; A61P1/00; A61P1/04; A61P17/00; A61P17/14; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P27/00; A61P27/02; A61P29/00; A61P3/00; A61P3/06; A61P31/00; A61P31/12; A61P35/00; A61P37/00; A61P37/02; A61P39/00; A61P39/02; A61P43/00; A61P5/00; A61P5/10; A61P9/00; C07D215/16; C07D215/20; C07D215/22; C07D215/36; C07D405/00; C07D405/02; C07D405/04

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 396 words
A compound of Formula 1 ##STR11## where Y is a bivalent radical having Formula 3 ##STR12## the two X 1 groups jointly represent an oxo (═O) or thione (═S) function, or X 1 is independently selected from H or alkyl of 1 to 6 carbons; the two X 2 groups jointly represent an oxo (═O) or a thione (═S) function, or X 2 is independently selected from H or alkyl of 1 to 6 carbons, with the proviso that one of the joint X 1 grouping or of the joint X 2 grouping represents an oxo (═O) or a thione (═S) function; W is O, C(R 1 ) 2 , or W does not exist; R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 2 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 is hydrogen, lower alkyl of I to 6 carbons, OR 1 , fluoro substituted lower alkyl of 1 to 6 carbons or halogen, NO 2 , NH 2 , NHCO(C 1 -C 6 alkyl, or NHCO(C 1 -C 6 )alkenyl; A is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , --CH 2 OH, CH 2 OR 11 , CH 2 OCOR 11 , CHO, CH(OR 12 ) 2 , CH(OR 13 O), --COR 7 , CR 7 (OR 12 ) 2 , CR 7 (OR 13 O), or Si(C 1-6 alkyl) 3 , where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons, and R 14 is H, alkyl of 1 to 10 carbons, fluoro-substituted alkyl of 1 to 10 carbons, alkenyl of 2 to 10 carbons and having 1 to 3 double bonds.
Claim 2
Dependent Claim 396 words
A compound of Formula 1 ##STR11## where Y is a bivalent radical having Formula 3 ##STR12## the two X 1 groups jointly represent an oxo (═O) or thione (═S) function, or X 1 is independently selected from H or alkyl of 1 to 6 carbons; the two X 2 groups jointly represent an oxo (═O) or a thione (═S) function, or X 2 is independently selected from H or alkyl of 1 to 6 carbons, with the proviso that one of the joint X 1 grouping or of the joint X 2 grouping represents an oxo (═O) or a thione (═S) function; W is O, C(R 1 ) 2 , or W does not exist; R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 2 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 is hydrogen, lower alkyl of I to 6 carbons, OR 1 , fluoro substituted lower alkyl of 1 to 6 carbons or halogen, NO 2 , NH 2 , NHCO(C 1 -C 6 alkyl, or NHCO(C 1 -C 6 )alkenyl; A is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , --CH 2 OH, CH 2 OR 11 , CH 2 OCOR 11 , CHO, CH(OR 12 ) 2 , CH(OR 13 O), --COR 7 , CR 7 (OR 12 ) 2 , CR 7 (OR 13 O), or Si(C 1-6 alkyl) 3 , where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons, and R 14 is H, alkyl of 1 to 10 carbons, fluoro-substituted alkyl of 1 to 10 carbons, alkenyl of 2 to 10 carbons and having 1 to 3 double bonds.
Claim 3
Dependent Claim 22 words
A compound in accordance with claim 1 where the two X 1 groups jointly represent an oxo (═O) or thione (═S) function.
Claim 4
Dependent Claim 23 words
A compound in accordance with claim 1 where the two X 2 groups jointly represent an oxo (═O) or a thione (═S) function.
Claim 5
Dependent Claim 214 words
A compound of the formula ##STR13## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 1 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, and R 14 * is alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 6
Dependent Claim 214 words
A compound of the formula ##STR13## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 1 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, and R 14 * is alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 7
Dependent Claim 15 words
A compound in accordance with claim 4 where R 2 * is CH 3 .
Claim 8
Dependent Claim 16 words
A compound in accordance with claim 5 where R 1 is H or CH 3 .
Claim 9
Dependent Claim 13 words
A compound in accordance with claim 6 where R 3 * is H.
Claim 10
Dependent Claim 19 words
A compound in accordance with claim 7 where R 14 * is lower alkyl of 1 to 6 carbons.
Claim 11
Dependent Claim 21 words
A compound in accordance with claim 8 where the cyclopropyl group is attached to the 6 position of the tetrahydroquinoline moiety.
Claim 12
Dependent Claim 25 words
A compound in accordance with claim 9 where the configuration about the cyclopropyl ring is cis, and the configurations about the double bonds are trans.
Claim 13
Dependent Claim 21 words
A compound in accordance with claim 10 where A* is COOH or a pharmaceutically acceptable salt thereof, or COOR 8 .
Claim 14
Dependent Claim 13 words
A compound in accordance with claim 11 where R 14 * is iso-propyl.
Claim 15
Dependent Claim 13 words
A compound in accordance with claim 12 where R 1 * is methyl.
Claim 16
Dependent Claim 26 words
A compound in accordance with claim 4, selected from the group consisting of: (6S,7S)-7-(4,4-dimethyl-2-oxo-1-(2-propyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, (6S,7S)-7-(4,4-dimethyl-2-oxo-1-(2-propyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, (6S,7S)-7-(4,4-dimethyl-1-(2-propyl)-2-thioxo-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, and (6S,7S)-7-(4,4-dimethyl-1-(2-propyl)-2-thioxo-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid.
Claim 17
Dependent Claim 241 words
A compound of the formula ##STR14## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 2 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, W* O, CH or CH 2 , with the proviso that when W* is CH then there are two R 14 * groups attached to it, and R 14 * is H, alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 18
Dependent Claim 241 words
A compound of the formula ##STR14## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 2 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, W* O, CH or CH 2 , with the proviso that when W* is CH then there are two R 14 * groups attached to it, and R 14 * is H, alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 19
Dependent Claim 15 words
A compound in accordance with claim 15 where R 2 * is CH 3 .
Claim 20
Dependent Claim 16 words
A compound in accordance with claim 16 where R 1 is H or CH 3 .
Claim 21
Dependent Claim 13 words
A compound in accordance with claim 17 where R 3 * is H.
Claim 22
Dependent Claim 19 words
A compound in accordance with claim 18 where R 14 * is lower alkyl of 1 to 6 carbons.
Claim 23
Dependent Claim 25 words
A compound in accordance with claim 19 where the configuration about the cyclopropyl ring is cis, and the configurations about the double bonds are trans.
Claim 24
Dependent Claim 21 words
A compound in accordance with claim 20 where A* is COOH or a pharmaceutically acceptable salt thereof, or COOR 8 .
Claim 25
Dependent Claim 15 words
A compound in accordance with claim 21 where R 14 * is methyl or tertiary-butyl.
Claim 26
Dependent Claim 13 words
A compound in accordance with claim 22 where R 1 * is methyl.
Claim 27
Dependent Claim 32 words
A compound in accordance with claim 15, selected from the group consisting of: (6S,7S)-7-(1-(tert-butyloxycarbonyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, (6S,7S)-7-(1-(tert-butyloxycarbonyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, (6S,7S)-7-(1-(Acetyl)-4,4-dimethyl-1,2,3,4-tetrahydro-quinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, (6S,7S)-7-(1-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydro-quinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, (6S,7S)-1-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-7-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, and (6S,7S)-7-(1-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-7-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-04-11 2003-10-11 2004-04-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-04-11 2007-10-11 2008-04-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-04-11 2011-10-11 2012-04-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag